Takayuki Kinoshita

Takayuki Kinoshita

UNVERIFIED PROFILE

Are you Takayuki Kinoshita?   Register this Author

Register author
Takayuki Kinoshita

Takayuki Kinoshita

Publications by authors named "Takayuki Kinoshita"

Are you Takayuki Kinoshita?   Register this Author

100Publications

-Reads

Knowledge, fatigue, and cognitive factors as predictors of lymphoedema risk-reduction behaviours in women with cancer.

Support Care Cancer 2018 Jul 16. Epub 2018 Jul 16.

Division of Cancer Survivorship Research, Center for Cancer Control and Information Services, National Cancer Center, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.

View Article
July 2018

TERT promoter hotspot mutations in breast cancer.

Breast Cancer 2018 May 8;25(3):292-296. Epub 2017 Dec 8.

Department of Breast and Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.

View Article
May 2018

Response to neoadjuvant chemotherapy for breast cancer judged by PERCIST - multicenter study in Japan.

Eur J Nucl Med Mol Imaging 2018 May 12. Epub 2018 May 12.

Department of Breast and Endocrine Surgery, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo, 663-8501, Japan.

View Article
May 2018

Rainbow of KIBOU (ROK) study: a Breast Cancer Survivor Cohort in Japan.

Breast Cancer 2018 Jan 25;25(1):60-67. Epub 2017 May 25.

Division of Health Sociology, Center for Public Health Sciences, National Cancer Center, 5-1-1 Tsukiji, Chuo, Tokyo, 104-0045, Japan.

View Article
January 2018

Visualization of HER2-specific breast cancer intratumoral heterogeneity using Cu-DOTA-trastuzumab PET.

Eur J Nucl Med Mol Imaging 2017 11 3;44(12):2146-2147. Epub 2017 Aug 3.

Department of Breast and Medical Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-Ku, Tokyo, 104-0045, Japan.

View Article
November 2017

Prognostic Significance of Progesterone Receptor Expression in Estrogen-Receptor Positive, HER2-Negative, Node-Negative Invasive Breast Cancer With a Low Ki-67 Labeling Index.

Clin Breast Cancer 2017 02 25;17(1):41-47. Epub 2016 Jun 25.

Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.

View Article
February 2017

[NONSURGICAL ABLATION THERAPY FOR SMALL BREAST CARCINOMAS].

Nihon Geka Gakkai Zasshi 2016 Nov;117(6):497-502

View Article
November 2016

Clinicopathological features of breast angiosarcoma.

Breast Cancer 2016 Sep 5;23(5):718-23. Epub 2015 Aug 5.

Breast Surgery Division, National Cancer Center Hospital, 1-1 Tsukiji 5-chome, Chuo-ku, Tokyo, 104-0045, Japan.

View Article
September 2016

Preoperatively diagnosed ductal carcinoma in situ: risk prediction of invasion and effects on axillary management.

Breast Cancer 2016 Sep 1;23(5):761-70. Epub 2015 Sep 1.

Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan.

View Article
September 2016

Prognostic Impact of Discordance in Hormone Receptor Status Between Primary and Recurrent Sites in Patients With Recurrent Breast Cancer.

Clin Breast Cancer 2016 08 14;16(4):e133-40. Epub 2016 May 14.

Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan; Department of Basic Pathology, National Defense Medical College, Saitama, Japan.

View Article
August 2016

Novel combination of serum microRNA for detecting breast cancer in the early stage.

Cancer Sci 2016 Mar 4;107(3):326-34. Epub 2016 Mar 4.

Division of Molecular and Cellular Medicine, Fundamental Innovative Oncology Core Center, National Cancer Center Research Institute, Tokyo, Japan.

View Article
March 2016

Comprehensive prognostic report of the Japanese Breast Cancer Society Registry in 2004.

Breast Cancer 2016 Jan 7;23(1):39-49. Epub 2015 Oct 7.

Department of Breast and Endocrine Surgery, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1193, Japan.

View Article
January 2016

Oncological safety of breast-conserving surgery after primary systemic chemotherapy in cT3-4 breast cancer patients.

Surg Today 2015 Oct 19;45(10):1255-62. Epub 2014 Oct 19.

Breast Surgery Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.

View Article
October 2015

TERT promoter mutations are frequent and show association with MED12 mutations in phyllodes tumors of the breast.

Br J Cancer 2015 Oct 10;113(8):1244-8. Epub 2015 Sep 10.

Division of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo 104-0045, Japan.

View Article
October 2015

Comprehensive prognostic report of the Japanese Breast Cancer Society Registry in 2005.

Breast Cancer 2015 Oct 13. Epub 2015 Oct 13.

Department of Breast and Endocrine Surgery, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1193, Japan.

View Article
October 2015

Comprehensive prognostic report of the Japanese Breast Cancer Society registry in 2006.

Breast Cancer 2015 Oct 13. Epub 2015 Oct 13.

Department of Breast and Endocrine Surgery, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1193, Japan.

View Article
October 2015

Utility of intraoperative frozen section examinations of surgical margins: implication of margin-exposed tumor component features on further surgical treatment.

Jpn J Clin Oncol 2015 Jan 15;45(1):19-25. Epub 2014 Oct 15.

Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo Department of Basic Pathology, National Defense Medical College, Saitama, Japan

View Article
January 2015

Sentinel lymph node biopsy in breast cancer patients with previous breast augmentation surgery.

Breast Cancer 2014 Sep 14;21(5):624-8. Epub 2011 Jun 14.

Department of Breast Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.

View Article
September 2014

Wide local extension and higher proliferation indices are characteristic features of symptomatic lobular neoplasias (LNs) and LNs with an early invasive component.

Histopathology 2014 Jun 8;64(7):994-1003. Epub 2014 Mar 8.

Department of Basic Pathology, National Defence Medical College, Tokorozawa, Japan; Department of Pathology and Clinical Laboratories, National Cancer Centre Hospital, Tokyo, Japan.

View Article
June 2014

Locoregional recurrence risk factors and the impact of postmastectomy radiotherapy on patients with tumors 5 cm or larger.

Breast Cancer 2014 May 14;21(3):292-301. Epub 2012 Aug 14.

Department of Breast Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.

View Article
May 2014

Synchronous unilateral triple breast cancers composed of invasive ductal carcinoma, invasive lobular carcinoma, and Paget's disease.

Breast Cancer 2014 Mar 8;21(2):241-5. Epub 2010 Dec 8.

Pathology Section, Clinical Laboratory Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuoku, Tokyo, 104-0045, Japan,

View Article
March 2014

Sentinel and nonsentinel lymph node assessment using a combination of one-step nucleic acid amplification and conventional histological examination.

Breast 2013 Dec 14;22(6):1194-9. Epub 2013 Sep 14.

Breast Surgery Division, National Cancer Center Hospital, Tokyo, Japan. Electronic address:

View Article
December 2013

Histological factors for accurately predicting first locoregional recurrence of invasive ductal carcinoma of the breast.

Cancer Sci 2013 Sep 25;104(9):1252-61. Epub 2013 Jul 25.

Diagnostic Pathology Section, Medical Support and Partnership Division, Center for Cancer Control and Information Services, National Cancer Center, Tokyo, Japan.

View Article
September 2013

Prognostic factors for stage IV hormone receptor-positive primary metastatic breast cancer.

Breast Cancer 2013 Apr 3;20(2):145-51. Epub 2011 Dec 3.

Breast and Medical Oncology Division , National Cancer Center Hospital, 5-1-1 Tsukiji, Chuou-ku, Tokyo, 104-0045, Japan.

View Article
April 2013

Locoregional recurrence risk factors in breast cancer patients with positive axillary lymph nodes and the impact of postmastectomy radiotherapy.

Int J Clin Oncol 2013 Feb 9;18(1):54-61. Epub 2011 Nov 9.

Department of Breast Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.

View Article
February 2013

Paclitaxel-induced peripheral neuropathy in patients receiving adjuvant chemotherapy for breast cancer.

Int J Clin Oncol 2013 Feb 22;18(1):132-8. Epub 2011 Nov 22.

Department of Breast Oncology and Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.

View Article
February 2013

Prognostic factors for triple-negative breast cancer patients receiving preoperative systemic chemotherapy.

Clin Breast Cancer 2013 Feb 25;13(1):40-6. Epub 2012 Oct 25.

Breast Surgery Division, National Cancer Center Hospital, Tokyo, Japan.

View Article
February 2013

[Current status and problems on preoperative hormone therapy].

Gan To Kagaku Ryoho 2012 Dec;39(13):2479-82

Department of Breast Oncology and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.

View Article
December 2012

Primary leiomyosarcoma of the breast.

Breast J 2012 Jan-Feb;18(1):81-2. Epub 2011 Nov 8.

Department of Breast Oncology, National Cancer Center Hospital, Tokyo, Japan.

View Article
September 2012

Comparative study of the value of dual tracer PET/CT in evaluating breast cancer.

Cancer Sci 2012 Sep 4;103(9):1701-7. Epub 2012 Jul 4.

Department of Radiology, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.

View Article
September 2012

A case of multidisciplinary treatment for a massive locoregional recurrence of breast cancer.

Jpn J Clin Oncol 2012 Sep;42(9):865

Breast Surgery Division, National Cancer Center Hospital, Tokyo, Japan.

View Article
September 2012

[Management for treatment of lobular carcinoma in situ (LCIS)].

Nihon Rinsho 2012 Sep;70 Suppl 7:397-400

Department of Breast Oncology and Medical Oncology, National Cancer Center Hospital.

View Article
September 2012

Sentinel lymph node biopsy using indigo carmine blue dye and the validity of '10% rule' and '4 nodes rule'.

Breast 2012 Aug 25;21(4):455-8. Epub 2011 Nov 25.

Department of Breast Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.

View Article
August 2012

The differences in the histological types of breast cancer and the response to neoadjuvant chemotherapy: the relationship between the outcome and the clinicopathological characteristics.

Breast 2012 Jun 25;21(3):289-95. Epub 2012 Jan 25.

Department of Breast Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.

View Article
June 2012

Loss of heterozygosity on chromosome 16q suggests malignancy in core needle biopsy specimens of intraductal papillary breast lesions.

Virchows Arch 2012 May 4;460(5):497-504. Epub 2012 Apr 4.

Division of Diagnostic Pathology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.

View Article
May 2012

Concordance of hospital-based cancer registry data with a clinicians' database for breast cancer.

J Eval Clin Pract 2012 Apr 30;18(2):459-64. Epub 2010 Nov 30.

Cancer Information Services and Surveillance Division, Center for Cancer Control and Information Services, National Cancer Center, Tokyo, Japan.

View Article
April 2012

Neoadjuvant chemotherapy in breast cancer: prediction of pathologic response with PET/CT and dynamic contrast-enhanced MR imaging--prospective assessment.

Radiology 2012 Apr;263(1):53-63

Department of Radiology, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa 236-0004, Japan.

View Article
April 2012

Prognostic significance of mitotic figures in metastatic mammary ductal carcinoma to the lymph nodes.

Hum Pathol 2011 Dec 17;42(12):1823-32. Epub 2011 Jun 17.

Pathology Consultation Service, Clinical Trials and Practice Support Division, Center for Cancer Control and Information Services, National Cancer Center, Chuo-ku, 104-0045, Tokyo, Japan.

View Article
December 2011

Feasibility of breast conserving surgery for Paget's disease.

Breast 2011 Dec;20(6):515-8

Breast Cancer Group, Surgical Oncology Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.

View Article
December 2011

Important histologic outcome predictors for patients with invasive ductal carcinoma of the breast.

Am J Surg Pathol 2011 Oct;35(10):1484-97

Pathology Consultation Service, Clinical Trials and Practice Support Division, Center for Cancer Control and Information Services, National Cancer Center Hospital, Tokyo, Japan.

View Article
October 2011

A case of metaplastic carcinoma of the breast.

Jpn J Clin Oncol 2011 Aug;41(8):1045

Breast Surgery Division, National Cancer Center Hospital, Tokyo, Japan.

View Article
August 2011

Atypical tumor-stromal fibroblasts in invasive ductal carcinomas of the breast treated with neoadjuvant therapy.

Hum Pathol 2011 Jul 11;42(7):998-1006. Epub 2011 Feb 11.

Clinical Trials and Practice Support Division, Pathology Consultation Service, Center for Cancer Control and Information Services, National Cancer Center, Tokyo, 104-0045, Japan.

View Article
July 2011

Preoperative therapy: recent findings.

Breast Cancer 2011 Apr 23;18(2):80-4. Epub 2010 Nov 23.

Department of Breast Surgery, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, Japan.

View Article
April 2011

Atypical tumor-stromal fibroblasts in invasive ductal carcinoma of the breast.

Am J Surg Pathol 2011 Mar;35(3):325-36

Clinical Trials and Practice Support Division, Pathology Consultation Service, Center for Cancer Control and Information Services, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan.

View Article
March 2011

Prognostic factors in young Japanese women with breast cancer: prognostic value of age at diagnosis.

Jpn J Clin Oncol 2011 Feb 14;41(2):180-9. Epub 2010 Oct 14.

Division of Breast Surgery, National Cancer Center Hospital, Tokyo, Japan.

View Article
February 2011

Radiofrequency ablation as local therapy for early breast carcinomas.

Breast Cancer 2011 Jan 14;18(1):10-7. Epub 2010 Jan 14.

Surgical Oncology Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, Japan.

View Article
January 2011

A histopathological study for evaluation of therapeutic effects of radiofrequency ablation in patients with breast cancer.

Breast Cancer 2011 Jan 23;18(1):24-32. Epub 2010 Sep 23.

Pathology and Clinical Laboratory Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, Japan.

View Article
January 2011

Up-regulation of PSF1 promotes the growth of breast cancer cells.

Genes Cells 2010 Oct 5;15(10):1015-24. Epub 2010 Sep 5.

Center for Medical Genomics, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.

View Article
October 2010

Metaplastic carcinoma of the breast.

Hum Pathol 2010 Jul 17;41(7):960-70. Epub 2010 Mar 17.

Pathology Consultation Service, Clinical Trials and Practice Support Division, Center for Cancer Control and Information Services, National Cancer Center, Tokyo 104-0045, Japan.

View Article
July 2010

Evaluation of sentinel node biopsy by combined fluorescent and dye method and lymph flow for breast cancer.

Breast 2010 Jun 13;19(3):210-3. Epub 2010 Feb 13.

National Cancer Center Hospital, Department of Surgery and Division of Breast Cancer, 5-1-1 Tsukiji Chuo-ku, Tokyo, Japan.

View Article
June 2010

Grading system for lymph vessel tumor emboli: significant outcome predictor for invasive ductal carcinoma of the breast.

Hum Pathol 2010 May 8;41(5):706-15. Epub 2010 Jan 8.

Pathology Consultation Service, Clinical Trials and Practice Support Division, Center for Cancer Control and Information Services, National Cancer Center, Tokyo 104-0045, Japan.

View Article
May 2010

p53 expression in tumor-stromal fibroblasts forming and not forming fibrotic foci in invasive ductal carcinoma of the breast.

Mod Pathol 2010 May 5;23(5):662-72. Epub 2010 Mar 5.

Pathology Consultation Service, Clinical Trials and Practice Support Division, Center for Cancer Control and Information Service, National Cancer Center, Chuo-ku, Tokyo, Japan.

View Article
May 2010

Grading system for lymph vessel tumor emboli: significant outcome predictor for patients with invasive ductal carcinoma of the breast who received neoadjuvant therapy.

Mod Pathol 2010 Apr 29;23(4):581-92. Epub 2010 Jan 29.

Pathology Consultation Service, Clinical Trials and Practice Support Division, Center for Cancer Control and Information Services, National Cancer Center, Tokyo, Japan.

View Article
April 2010

p53 expression in tumor-stromal fibroblasts is closely associated with the nodal metastasis and outcome of patients with invasive ductal carcinoma who received neoadjuvant therapy.

Hum Pathol 2010 Feb;41(2):262-70

Clinical Trials and Practice Support Division, Pathology Consultation Service, Center for Cancer Control and Information Services, National Cancer Center, Tokyo 104-0045, Japan.

View Article
February 2010

p53 expression in tumor stromal fibroblasts is associated with the outcome of patients with invasive ductal carcinoma of the breast.

Cancer Sci 2009 Nov 6;100(11):2101-8. Epub 2009 Aug 6.

Pathology Consultation Service, Clinical Trials and Practice Support Division, Center for Cancer Control and Information Services, National Cancer Center, Tokyo, Japan.

View Article
November 2009

Clinical and pathological features of intracystic papillary carcinoma of the breast.

Surg Today 2009 8;39(1):5-8. Epub 2009 Jan 8.

Division of Breast Surgery, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.

View Article
April 2009

A case of ductal carcinoma in situ of the breast.

Jpn J Clin Oncol 2009 Feb;39(2):132

Breast Surgery Division, National Cancer Center Hospital, Tokyo, Japan.

View Article
February 2009